Related Experiment Videos
Hemoglobin screening for normal newborns
Summary
The HemoCue system, a rapid hemoglobin test, may not replace the spun hematocrit for screening newborn infants for anemia and polycythemia due to lower readings. Further research is needed for this common newborn screening test.
Area of Science:
- Neonatal Medicine
- Clinical Pathology
- Hematology
Background:
- Spun hematocrit is a standard newborn screening test for anemia and polycythemia.
- The HemoCue system offers safer, faster, and less invasive hemoglobin screening in other populations.
- Widespread adoption of HemoCue in hospitals is limited, but it's used in blood banks and clinics.
Purpose of the Study:
- To evaluate if HemoCue hemoglobin values can substitute for spun hematocrit in screening normal newborn infants.
- To compare HemoCue hemoglobin results with laboratory-analyzed hematocrit and hemoglobin values in neonates.
Main Methods:
- Collected 54 specimens from healthy, term newborn infants.
- Compared HemoCue hemoglobin readings with laboratory hematocrit and hemoglobin values.
- Analyzed specimens drawn in the nursery and processed in the lab.
Main Results:
- HemoCue hemoglobin values were consistently lower than hematocrit values (approximately one-third).
- A significant, systematic difference was observed between HemoCue nursery readings and laboratory hematology analyzer results.
- HemoCue readings were slightly lower across all tested specimens.
Conclusions:
- The HemoCue system's hemoglobin values showed a consistent and significant difference compared to laboratory methods in newborn infants.
- The HemoCue system may not be a suitable replacement for spun hematocrit in screening neonates for anemia and polycythemia.
- Further validation is required before implementing HemoCue for routine newborn screening.